Biopure Corporation
(NASDAQ:BPUR)|
0.11 -0.02 (-15.38%) Dec 02 - Close |
|
|
|
After-Hours 0.18 +0.07 (63.64%) Tue, 2 Dec 2008 7:40 PM
- Compare BPUR with:
- View: Line | Candlestick
Company Profile
Biopure Corporation
11 Hurley Street
Cambridge, MA 02141
United States - Map
Phone: (617) 234-6500
Fax: (617) 234-6505
Website: www.biopure.com
State of incorporation: Delaware
CEO: Zafiris G. Zafirelis
Employees: 86
Sector: Healthcare
Industry Group: Drugs
Industry: Biotechnology
Prov, manufacturer & marker of oxygen therapeutics
The Company develops, markets and manufactures pharmaceuticals, called oxygen therapeutics that are intravenously administered to deliver oxygen to the body's tissues.
Recent news for BPUR
-
PR Newswire - 4 hours ago
-
BIOPURE CORP Files SEC form 8-K, Change in Directors or Principal Officers, Other Events
EDGAR Online - Nov 21 at 8:31 ET
-
Agency Takes Adverse Decision to Biopure's Product Registration in South Africa
PR Newswire - Oct 28 at 3:15 ET
-
Biopure Sues National Institutes of Health Official
PR Newswire - Oct 28 at 3:05 ET
-
EDGAR Online - Oct 28 at 8:26 ET
-
Biopure Receives Extension of Time to Regain NASDAQ Listing Compliance
PR Newswire - Oct 28 at 7:30 ET
-
EDGAR Online Financials - Sep 19 at 8:04 ET
-
BIOPURE CORP Files SEC form 10-Q, Quarterly Report
EDGAR Online - Sep 15 at 4:08 ET
-
EDGAR Online - Aug 22 at 6:56 ET
-
BIOPURE CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
EDGAR Online - Jul 31 at 3:57 ET